首页> 外文OA文献 >Glomerulopathy in rats with streptozotocin diabetes. Accumulation of glomerular basement membrane analogous to human diabetic nephropathy
【2h】

Glomerulopathy in rats with streptozotocin diabetes. Accumulation of glomerular basement membrane analogous to human diabetic nephropathy

机译:链脲佐菌素糖尿病大鼠肾小球病。类似于人糖尿病性肾病的肾小球基底膜积聚

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glomeruli from streptozotocin-diabetic and age-matched nondiabetic rats were quantitatively isolated by a differential sieving technique. The insoluble glomerular basement membranes were purified following sonic disruption in the presence of proteolytic inhibitors. The yield of glomeruli and of glomerular basement membrane relative to the amount of renal cortex and the body weight of the animals, as well as the calculated amount of basement membrane per glomerulus, were all significantly greater in diabetic rats when compared to non-diabetic controls. Glomerular basement membranes from normal and diabetic rats were solubilized by reduction and denaturation in the presence of SDS and subjected to agarose gel analysis. About 65% of both normal and diabetic basement membrane was solubilized by this procedure, and the elution profiles of non-diabetic and diabetic preparations were similar. These results suggest that rat renal basement membrane is qualitatively similar but quantitatively increased in streptozotocin- diabetes. Since glomerular enlargement and accumulation of basement membrane are characteristic of human diabetic nephropathy, the findings also suggest that the streptozotocin-diabetic rat is an appropriate animal model for studies relating to the pathogenesis of this complication of diabetes.
机译:通过差异筛分技术定量分离了链脲佐菌素和年龄匹配的非糖尿病大鼠的肾小球。在蛋白水解抑制剂存在下进行声波破坏后,纯化不溶性肾小球基底膜。与非糖尿病对照组相比,糖尿病大鼠肾小球和肾小球基底膜的产量相对于肾皮质和动物体重的量,以及每只肾小球的基底膜的计算量均明显更高。 。在SDS存在下,通过还原和变性将正常和糖尿病大鼠的肾小球基底膜溶解,并进行琼脂糖凝胶分析。正常和糖尿病基底膜中约有65%通过此程序溶解,非糖尿病和糖尿病制剂的洗脱曲线相似。这些结果表明,在链脲佐菌素-糖尿病中,大鼠肾基底膜在质上相似,但在数量上有所增加。由于肾小球增大和基膜的蓄积是人类糖尿病肾病的特征,因此该发现还表明,链脲佐菌素-糖尿病大鼠是用于研究与该糖尿病并发症的发病机制有关的合适的动物模型。

著录项

  • 作者

  • 作者单位
  • 年度 1979
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号